Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2024 | Story EDZANI NEPHALELA | Photo ANJA AUCAMP
Dr Martin Laubscher
Dr Martin Laubscher’s thesis, crowned with the Andrew Murray-Desmond Tutu Prize, is testament to the university’s unwavering commitment to scholarly excellence.

In a historic triumph that reverberates over four decades since its inception, the UFS has clinched the coveted Andrew Murray Prize – now renamed the Andrew Murray-Desmond Tutu Prize – for the first time. Standing shoulder to shoulder with institutions such as the University of Pretoria (UP) and Stellenbosch University (SU), this achievement marks a significant milestone in the UFS’ journey.

At the heart of this accomplishment lies the profound contribution of Dr Martin Laubscher, distinguished Senior Lecturer specialising in Practical and Missional Theology in the Faculty of Theology and Religion. Dr Laubscher’s dedication and scholarly prowess culminated in the groundbreaking work titled Publieke teologie as profetiese teologie? (Public theology as prophetic theology), a revised edition of his doctoral thesis, which was originally crafted at Stellenbosch University in 2020, with a focus on the eminent Karl Barth.

Dr Laubscher received the Andrew Murray Prize for Theological Books in Afrikaans for his research and insightful analysis. The journey started when he realised, under the guidance of his study leader, Prof Dion Forster, that his script had the potential to be published in Afrikaans. Sun Media’s interest in publishing this work in Afrikaans, led to it being the first-ever published thesis in Afrikaans. Dr Laubscher recalls, “I was grateful and excited about Sun Media’s interest. The book emerged within a year, and during a celebratory launch Prof Forster suggested I submit it for the Andrew Murray Prize.”

Earlier this year, Dr Laubscher was excited to learn that he was being shortlisted for the prestigious award. Reflecting on the significant moment, he shares, “The elation I felt upon receiving the news was unparalleled. I was not only celebrating a personal triumph, but also etching my name as the first laureate from our faculty to secure this prestigious accolade.”

News Archive

UFS takes a leading role in nuclear medicine and technology
2011-12-06

 
Photo: Dr Glen Taylor

The University of the Free State (UFS) continues to play an active role in the field of Nuclear Medicine and the use of nuclear technology in the biosciences. Dr Glen Taylor, Director of Research Commercialisation and Business Development at the UFS, was recently elected chairperson of the board for the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI).

The UFS is currently one of three centres of excellence in the country identified by the Nuclear Energy Corporation South African (Necsa) to roll out the capacity development programme and increase technology coming from nuclear medicine and technology.
NTeMBI is a national technology platform that is managed by Necsa and supported by the Department of Science and Technology (DST). It functions as a high-level Research, Development and Innovation (RD&I) initiative that will implement new strategic initiatives relating to research and development on nuclear technologies in medicine and the biosciences on a local, regional and international level. 
 
One of the roles Dr Taylor will perform as Chairperson of the board of NTeMBI, is to enhance the exposure of nuclear technology in medicine and the biosciences. Dr Taylor says the aim is to increase the skills base in South Africa. “I realise it is one of the scare skills in the country.” 
 
The UFS already received a significant amount of funding from the grant of R4 million per annum made available from the Department of Science and Technology (DST) to implement NTeMBI projects.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept